Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

By John P. DiMarco, MD, PhD Professor of Medicine, Division of Cardiology, University of Virginia, Charlottesville Dr. DiMarco is a consultant for Novartis and does research for Medtronic and Guidant. Synopsis: Pulmonary vein isolation is a feasible first-line approach for this treatment of selected patients with symptomatic atrial fibrillation. Source: Wazni OM, et.al. Radiofrequency Ablation vs Antiarrhthymic Drugs as First-Line Treatment of Symptomatic Atrial Fibrillation: A Randomized Trial. JAMA. 2005; 293:2634-2640.

Ablation vs Antiarrhythmic for Symptomatic Atrial Fibrillation